Literature DB >> 9673448

Control of osteoclast differentiation.

S V Reddy1, G D Roodman.   

Abstract

The osteoclast is the primary bone-resorbing cell and is derived from the monocyte/macrophage lineage. Bipotent osteoclast precursors, which can form both osteoclasts and monocyte-macrophages, proliferate and differentiate to become unipotent post-mitotic committed osteoclast precursors. These post-mitotic committed precursors fuse to form the multinucleated osteoclast, which is then activated to resorb bone. A variety of soluble and membrane-bound factors play a critical role in regulating osteoclast formation, including growth factors, systemic hormones, and cells in the marrow microenvironment, such as osteoblasts and marrow stromal cells. Cell-to-cell interactions are important in both the formation and activity of the osteoclast. Recent molecular biological studies have identified transcription factors, such as c-fos and PU.1, which are required for osteoclast differentiation. In this review, we discuss the phenotypic changes that are induced as the cells mature from bipotent early precursors to mature osteoclasts; factors that have been identified that are involved in this process; and the role of marrow stromal cells and osteoblasts in osteoclast differentiation.

Entities:  

Mesh:

Year:  1998        PMID: 9673448     DOI: 10.1615/critreveukargeneexpr.v8.i1.10

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  12 in total

1.  Interleukin-1 and tumor necrosis factor receptor signaling is not required for bacteria-induced osteoclastogenesis and bone loss but is essential for protecting the host from a mixed anaerobic infection.

Authors:  C P Chen; M Hertzberg; Y Jiang; D T Graves
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Structure of the SH3 domain of human osteoclast-stimulating factor at atomic resolution.

Authors:  Liqing Chen; Yujun Wang; David Wells; Diana Toh; Hunt Harold; Jing Zhou; Enrico DiGiammarino; Edward J Meehan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-18

Review 3.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

4.  Crystallization and preliminary X-ray crystallographic analysis of osteoclast-stimulating factor.

Authors:  Ming Li; Zhaohui Meng; Yanhui Xu; Zhiyong Lou; Zihe Rao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2004-12-24

5.  Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures.

Authors:  C Menaa; R D Devlin; S V Reddy; Y Gazitt; S J Choi; G D Roodman
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

6.  Newly recruited human monocytes have a preserved responsiveness towards bacterial peptides in terms of CD11b up-regulation and intracellular hydrogen peroxide production.

Authors:  E Dadfar; S H Jacobson; J Lundahl
Journal:  Clin Exp Immunol       Date:  2007-03-26       Impact factor: 4.330

7.  Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.

Authors:  Y Okada; J A Lorenzo; A M Freeman; M Tomita; S G Morham; L G Raisz; C C Pilbeam
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

8.  Induction of osteoclastogenesis and matrix metalloproteinase expression by the lipooligosaccharide of Treponema denticola.

Authors:  Bong-Kyu Choi; Hyun Jung Lee; Jung Hwa Kang; Gook Jin Jeong; Cheon Ki Min; Yun-Jung Yoo
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  The effects of tualang honey on bone metabolism of postmenopausal women.

Authors:  Nadia Mohd Effendy; Norazlina Mohamed; Norliza Muhammad; Isa Naina Mohamad; Ahmad Nazrun Shuid
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-29       Impact factor: 2.629

10.  Using a novel microRNA delivery system to inhibit osteoclastogenesis.

Authors:  Yanlan Yao; Tingting Jia; Yang Pan; Hongna Gou; Yulong Li; Yu Sun; Rui Zhang; Kuo Zhang; Guigao Lin; Jiehong Xie; Jinming Li; Lunan Wang
Journal:  Int J Mol Sci       Date:  2015-04-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.